NCT06446505

Brief Summary

The goal of this clinical trial is to learn if a Decision Aid can help patients with Parkinson's disease make a decision about undergoing Deep Brain Stimulation surgery. The main questions it aims to answer are:

  • Is the Decision Aid acceptable to patients with Parkinson's disease considering Deep Brain Stimulation surgery?
  • Does the decision aid improve decision quality (informed, value-based decision) and uncertainty about the decision? Researchers will compare immediate use of the decision aid during the evaluation process for deep brain stimulation surgery to delayed introduction of the decision aid. Participants will:
  • Receive the decision aid at the beginning of the evaluation process or towards the end
  • Complete surveys at 5 visits (remote or in-person) over approximately 6 months

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
1mo left

Started Jun 2024

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jun 2024Jul 2026

First Submitted

Initial submission to the registry

May 22, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

June 6, 2024

Status Verified

June 1, 2024

Enrollment Period

2.1 years

First QC Date

May 22, 2024

Last Update Submit

June 4, 2024

Conditions

Keywords

Deep Brain StimulationDecision Aid

Outcome Measures

Primary Outcomes (7)

  • Acceptability tool from the Ottawa Hospital Research Institute

    This tool measures the comprehensibility of components of the decision aid including its length, amount of information, balance and suitability for decision-making. Higher scores indicate that the tool is more acceptable.

    Baseline

  • Acceptability tool from the Ottawa Hospital Research Institute

    This tool measures the comprehensibility of components of the decision aid including its length, amount of information, balance and suitability for decision-making. Higher scores indicate that the tool is more acceptable.

    2 weeks after decision for deep brain stimulation surgery

  • Decisional Conflict Scale (DCS)

    The Decisional Conflict Scale measures the perceptions of uncertainty in choosing options, including uncertainty related to feeling uninformed, unclear about personal values and unsupported in decision-making. The minimum score is a 0 and the maximum score is 100. Higher scores indicate more decisional conflict.

    Baseline

  • Decisional Conflict Scale (DCS)

    The Decisional Conflict Scale measures the perceptions of uncertainty in choosing options, including uncertainty related to feeling uninformed, unclear about personal values and unsupported in decision-making. The minimum score is a 0 and the maximum score is 100. Higher scores indicate more decisional conflict.

    1 Month

  • Decisional Conflict Scale (DCS)

    The Decisional Conflict Scale measures the perceptions of uncertainty in choosing options, including uncertainty related to feeling uninformed, unclear about personal values and unsupported in decision-making. The minimum score is a 0 and the maximum score is 100. Higher scores indicate more decisional conflict.

    3 Months

  • Decisional Conflict Scale (DCS)

    The Decisional Conflict Scale measures the perceptions of uncertainty in choosing options, including uncertainty related to feeling uninformed, unclear about personal values and unsupported in decision-making. The minimum score is a 0 and the maximum score is 100. Higher scores indicate more decisional conflict.

    2 weeks after decision for deep brain stimulation surgery

  • Decisional Conflict Scale (DCS)

    The Decisional Conflict Scale measures the perceptions of uncertainty in choosing options, including uncertainty related to feeling uninformed, unclear about personal values and unsupported in decision-making. The minimum score is a 0 and the maximum score is 100. Higher scores indicate more decisional conflict.

    2 months post-Deep brain stimulation surgery or 2 months post decision not to undergo surgery

Secondary Outcomes (22)

  • Decision Quality Worksheet

    2 weeks after decision for deep brain stimulation surgery

  • Decision Quality Worksheet

    2 months post-Deep brain stimulation surgery or 2 months post decision not to undergo surgery

  • Decision Self-Efficacy scale

    Baseline

  • Decision Self-Efficacy scale

    3 Months

  • Decision Self-Efficacy scale

    2 weeks after decision for deep brain stimulation surgery

  • +17 more secondary outcomes

Study Arms (2)

Early Decision Aid

EXPERIMENTAL

Participants will receive the Decision Aid at baseline.

Other: Deep Brain Stimulation Decision Aid

Delayed Decision Aid

ACTIVE COMPARATOR

Participants will receive the Decision Aid at the end of the deep brain stimulation surgery evaluation process.

Other: Deep Brain Stimulation Decision Aid

Interventions

An online decision support tool that provides education about deep brain stimulation and the alternatives, and includes value clarification exercise.

Delayed Decision AidEarly Decision Aid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with a diagnosis of Parkinson's disease referred for deep brain stimulation surgery evaluation at the University of Colorado

You may not qualify if:

  • Atypical Parkinsonism
  • Diagnosis of Dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Anschutz

Aurora, Colorado, 80045, United States

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Michelle E Fullard, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2024

First Posted

June 6, 2024

Study Start

June 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

June 6, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

We plan to share the de-identified dataset after the primary results have been accepted for publication. No patient identifiers will be included in the shared data.

Locations